CLINICAL_TRIALS
trial_result
· 2019-04-29
Clinical Trial Update: Transcranial Magnetic Stimulation to Improve Gesture Control [Phase 1, Phase 2]
Summary
Phase 1/Phase 2 clinical trial update on transcranial magnetic stimulation to improve gesture control in schizophrenia-related disorders.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Bern | Conditions: Schizophrenia and Related Disorders | Phase 1, Phase 2 | Status: COMPLETED